GST, CYP and PON1 polymorphisms in farmers attributing ill health to organophosphate-containing sheep dip

References

• Abel EL, Bammler TK, Eaton DL. Biotransformation of methyl parathion by glutathione S-transferases. Toxicological Sciences 2004; 79: 224–232
   PubMed Web of Science ®Google Scholar
• Ali–Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterisation, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalyic activity of the encoded proteins. Journal of Biological Chemistry 1997; 272: 10004–10012
   PubMed Web of Science ®Google Scholar
• Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002; 3: 229–243
   PubMed Web of Science ®Google Scholar
• Cherry N, Creed F, Silman A, Dunn G, Baxter D, Smedley J, Taylor S, Macfarlane GJ. Health and exposures of United Kingdom Gulf War Veterans. Part I: the pattern and extent of ill health. Occupational and Environmental Medicine 2001; 58: 291–298
   PubMed Web of Science ®Google Scholar
• Cherry NM, Mackness M, Durrington P, Povey AC, Dippnall WM, Smith AE, Mackness B. Paraoxonase (PON1) polymorphisms in farmers attributing ill-health to sheep dip. Lancet 2002; 359: 763–764
   PubMed Web of Science ®Google Scholar
• Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. 1999. Organophosphates. London: Department of Health.
   Google Scholar
• Costa LG, Cole TB, Jarvik GP, Furlong CE. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annual Review of Medicine 2003; 54: 371–392
   PubMed Web of Science ®Google Scholar
• Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genetics 1996; 14: 334–336
   PubMed Web of Science ®Google Scholar
• Dillon HH, Ho MH. Biological monitoring of exposure to organophosphorus pesticides. Biological Monitoring of Exposure to Chemicals. Organic Compounds, MH Ho, HH Dillon. John Wiley & Sons, New York 1987; 227–287
   Google Scholar
• Donn, R, Alourfi, Z, De Benedetti, F, Meazza, C, Zeggini, E, Lunt, M, Stevens, A, Shelley, E, Lamb, R, Ollier, WER, Thompson, W, Ray, D, the British Paediatric Rheumatology Study Group. 2002. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis and Rheumatism. 46:2402–2409.
   Google Scholar
• Eaton DL. Biotransformation enzyme polymorphism and pesticide susceptibility. Neurotoxicology 2000; 21: 101–112
   PubMed Web of Science ®Google Scholar
• Fabrizi L, Gemma S, Testai E, Vittozzi L. Identification of the cytochrome p450 isoenzymes involved in the metabolism of diazinon in the rat liver. Journal of Biochemical and Molecular Toxicology 1999; 13: 53–61
   PubMed Web of Science ®Google Scholar
• Furlong CE, Li WF, Richter RJ, Shih DM, Lusis AJ, Alleva E, Costa LG. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicology 2000; 21: 91–100
   PubMed Web of Science ®Google Scholar
• Garin MC, James RW, Dussoix P, Blanche M, Passa P, Froguel P, Ruiz J. Paraoxonase polymorphism Met–Leu 54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. Journal of Clinical Investigation 1997; 99: 62–66
   PubMed Web of Science ®Google Scholar
• Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW, Bell D. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. Journal of the National Cancer Institute 1998; 90: 512–518
   PubMed Web of Science ®Google Scholar
• Hernandez AF, Mackness B, Rodrigo L, Lopez O, Pla A, Gil F, Durrington PN, Pena G, Perron T, Serrano JL, Mackness MI. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long-term pesticide exposure. Human and Experimental Toxicology 2003; 22: 505–574
   Google Scholar
• Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis for the human serum paraoxonase activity polymorphism. Nature Genetics 1993; 3: 73–76
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. Genetic polymorphisms of cytochrome p450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics Journal 2005; 5: 6–13
   PubMed Web of Science ®Google Scholar
• Jokanovic M. Biotransformation of organophosphorus compounds. Toxicology 2001; 166: 139–160
   PubMed Web of Science ®Google Scholar
• Kappers WA, Edwards RJ, Murray S, Boobis AR. Diazinon is activated by CYP2C19 in human liver. Toxicology and Applied Pharmacology 2001; 177: 68–76
   PubMed Web of Science ®Google Scholar
• Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics 2001; 27: 383–391
   PubMed Web of Science ®Google Scholar
• La Du BN, Billecke S, Hsu C, Haley RW, Broomfield CA. Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes effecting individual sensitivity to environmental chemicals. Drug Metabolism and Disposition 2001; 29: 566–569
   PubMed Web of Science ®Google Scholar
• Lamba JK, Lin YS, Schuetz EG, Thumme KE. Genetic contribution to variable human CYP3A-mediated metabolism. Advances in Drug Delivery Reviews 2002; 54: 1271–1290
   PubMed Web of Science ®Google Scholar
• Lee BW, London L, Paulauskis J, Myers J, Christiani DC. Association between human paraoxonase gene polymorphisms and chronic symptoms in pesticide-exposed workers. Journal of Occupational and Environmental Medicine 2003; 45: 118–122
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Cherry NM, McLNiven R, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Letters 2002; 180: 165–171
   PubMed Web of Science ®Google Scholar
• Li W-F, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE. Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphorous compounds. Pharmacogenetics 2000; 10: 767–779
   PubMedGoogle Scholar
• Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. General Pharmacology 1998a; 31: 329–336
   PubMedGoogle Scholar
• Mackness B, Mackness MI, Arrol T, Turkie W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modifications. FEBS Letters 1998b; 423: 57–60
   PubMed Web of Science ®Google Scholar
• Mackness B, Durrington P, Povey AC, Thomson S, Middleton S, Dippnall M, Mackness M, Smith AR, Cherry NM. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics 2003; 13: 81–88
   PubMedGoogle Scholar
• May DG, Porter J, Wilkinson GR, Branch RA. Frequency distribution of dapsone N-hydroxylase, a putative probe for p4503A4 activity in a white population. Clinical Pharmacology and Therapeutics 1994; 55: 492–500
   PubMed Web of Science ®Google Scholar
• Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides and glutathione transferase polymorphisms. Lancet 1998; 352: 1344–1346
   PubMed Web of Science ®Google Scholar
• Mizutani T. PM frequencies of major CYPs in Asians and Caucasians. Drug Metabolism Reviews 2003; 35: 99–106
   PubMed Web of Science ®Google Scholar
• Motoyama N, Dauterman WC. Glutathione S-transferases: their role in the metabolism of organophosphorous insecticides. Reviews in Biochemical Toxicology 1980; 2: 49–69
   Google Scholar
• Mutch E, Blain PG, Williams FM. The role of metabolism in determining susceptibility to parathion toxicity in man. Toxicology Letters 1999; 107: 177–187
   PubMed Web of Science ®Google Scholar
• Povey AC, Guppy MJ, Hall CN, Jackson PE, Badawi AF, Cooper DP, O'Connor PJ, Margison GP. Host determinants of DNA alkylation and DNA repair activity in human colorectal tissue: O6-methylguanine levels are associated with GST-T1 genotype and O6-alkylguanine-DNA alkyltransferase activity with CYP2D6 genotype. Mutation Research 2001; 495: 103–115
   PubMedGoogle Scholar
• Povey AC, Mackness MI, Durrington PN, Dippnall M, Smith AE, Mackness B, Cherry NM. Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep. Occupational Medicine 2005; 55: 282–286
   PubMedGoogle Scholar
• Rebbeck TR. Molecular epidemiology of the human glutathione s-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiology Biomarkers Prevention 1997; 6: 733–743
   PubMed Web of Science ®Google Scholar
• Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Journal of the National Cancer Institute 1998; 90: 1225–1229
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians of London and the Royal College of Psychiatrists. 1998. Organophosphate sheep dip: clinical aspects of long term low-dose exposure. London: Royal College of Physicians of London and the Royal College of Psychiatrists.
   Google Scholar
• Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. American Journal of Human Genetics 1997; 60: 284–289
   PubMed Web of Science ®Google Scholar
• Sams C, Mason HJ, Rawbone R. Evidence for the activation of organophosphate pesticides by cytochromes p450 3A4 and 2D6 in human liver microsomes. Toxicology Letters 2000; 116: 217–221
   PubMed Web of Science ®Google Scholar
• Sams C, Cocker J, Lennard MS. Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome p450s (CYP). Xenobiotica 2004; 34: 861–873
   PubMed Web of Science ®Google Scholar
• Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ. CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clinical Pharmacology and Therapeutics 2000; 67: 48–56
   PubMed Web of Science ®Google Scholar
• Shih DM, Gu L, Xia Y–R, Navab M, Li W–F, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. Mice lacking serum paroxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284–287
   PubMed Web of Science ®Google Scholar
• Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339: 1375–1377
   PubMed Web of Science ®Google Scholar
• Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutation Research 2001; 482: 21–26
   PubMed Web of Science ®Google Scholar
• Sultatos LG. Role of glutathione in the mammalian detoxication of organophosphorus insecticides. Organophosphates: chemistry, fate and effects, JE Chambers, PE Levi. Academic Press, San Diego 1992; 155–168
   Google Scholar
• Thier R, Pemble SE, Kramer H, Taylor JB, Guengerich FP, Ketterer B. Human glutathione S-transferase T1-1 enhances mutagenicity of 1,2-dibromoethane, dibromomethane and 1,2,3,4-diepoxybutane in Salmonella typhimurium. Carcinogenesis 1996; 17: 163–166
   PubMed Web of Science ®Google Scholar
• Westlind A, Lofberg L, Tindber N, Andersson TB, Ingelman-Sundberg M. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochemical and Biophysical Research Communications 1999; 259: 201–205
   PubMed Web of Science ®Google Scholar
• Wolf CR, Smith G. Cytochrome P450 CYP2D6. IARC Scientific Publications 1999; 148: 209–229
   PubMedGoogle Scholar
• Zanger UM, Raimundo S, Eichelbaum M. Cytochrome p450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn-Schmiedeberg's Archives of Pharmacology 2004; 369: 23–37
   PubMed Web of Science ®Google Scholar